Frank Buehling

Title: Frank Buehling: Innovator in Enzyme Inhibition

Introduction

Frank Buehling is a notable inventor based in Magdeburg, Germany. He has made significant contributions to the field of enzyme inhibition, particularly in relation to immune cell proliferation. His innovative work has implications for the treatment of autoimmune diseases and chronic inflammatory conditions.

Latest Patents

Frank Buehling holds a patent for "Combinations of enzyme inhibitor-containing preparations and the use thereof." This invention outlines a process that inhibits DNA synthesis and the proliferation of mononuclear cells and T cells through the combined inhibition of various enzyme activities. The patent emphasizes that the simultaneous application of multiple enzyme inhibitors results in a more effective therapeutic outcome than using a single inhibitor alone.

Career Highlights

Buehling is associated with Imtm GmbH, where he continues to develop and refine his innovative approaches to enzyme inhibition. His work is characterized by a deep understanding of enzymatic processes and their impact on immune responses.

Collaborations

Frank Buehling has collaborated with notable colleagues, including Klaus Neubert and Dirk Reinhold. These partnerships have enhanced the research and development of his patented technologies.

Conclusion

Frank Buehling's contributions to enzyme inhibition represent a significant advancement in therapeutic strategies for autoimmune and chronic inflammatory diseases. His innovative approach continues to influence the field and offers hope for improved treatment options.